Gene · 7941
Papers4,339
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 4,339
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CardiOmics signatures reveal therapeutically actionable targets and drugs for cardiovascular diseases. | Heliyon | 2024 | 38187312 | PubTator, text mining | PubMed |
| Translational medicine for acute lung injury. | J Transl Med | 2024 | 38183140 | PubTator, text mining | PubMed |
| Identification of clinical prognostic factors and analysis of ferroptosis-related gene signatures in the bladder cancer immune microenvironment. | BMC Urol | 2024 | 38172792 | PubTator, text mining | PubMed |
| miR-378a-5p exerts tumor-suppressive effects on esophageal squamous cell carcinoma after neoadjuvant immunotherapy by downregulating APOC1/CEP55. | Sci Rep | 2024 | 38172247 | PubTator, text mining | PubMed |
| Anaphylaxis mortality in the perioperative setting: Epidemiology, elicitors, risk factors and knowledge gaps. | Clin Exp Allergy | 2024 | 38168878 | PubTator, text mining | PubMed |
| Effect of probiotic supplementation on lipoprotein-associated phospholipase A2 in type 2 diabetic patients: a randomized double blind clinical controlled trial. | Nutr Metab (Lond) | 2024 | 38167029 | PubTator, text mining | PubMed |
| Association between dietary inflammatory index and Stroke in the US population: evidence from NHANES 1999-2018. | BMC Public Health | 2024 | 38166986 | PubTator, text mining | PubMed |
| Moderate-Intensity Rosuvastatin/Ezetimibe Combination versus Quadruple-Dose Rosuvastatin Monotherapy: A Meta-Analysis and Systemic Review. | Yonsei Med J | 2024 | 38154476 | PubTator, text mining | PubMed |
| Causal Effect of Lipoprotein-Associated Phospholipase A2 Activity on Ischemic Stroke: A Mendelian Randomization Study. | Cerebrovasc Dis | 2024 | 38113871 | PubTator, text mining | PubMed |
| Associations between healthy food groups and platelet-activating factor, lipoprotein-associated phospholipase A2 and C-reactive protein: a cross-sectional study. | Eur J Nutr | 2024 | 38063929 | PubTator, text mining | PubMed |
| Research Advance of Chinese Medicine in Treating Atherosclerosis: Focus on Lipoprotein-Associated Phospholipase A2. | Chin J Integr Med | 2024 | 38057549 | PubTator, text mining | PubMed |
| PI3K signaling promotes formation of lipid-laden foamy macrophages at the spinal cord injury site. | Neurobiol Dis | 2024 | 38049013 | PubTator, text mining | PubMed |
| Linking biomarkers with healthy lifestyle outcomes after stroke: Supplementary results of a 12-month randomized controlled trial. | Nutr Metab Cardiovasc Dis | 2024 | 37949707 | PubTator, text mining | PubMed |
| Correlation of Serum β2-MG, HGF, Lp-PLA2 with Carotid Atherosclerosis in Patients with Hypertension Combined with Cerebral Infarction and their Prognostic Value. | Altern Ther Health Med | 2024 | 37883762 | PubTator, text mining | PubMed |
| Excessive daytime sleepiness, morning tiredness, and prognostic biomarkers in patients with chronic coronary syndrome. | Int J Cardiol | 2024 | 37748524 | PubTator, text mining | PubMed |
| Gender-related and PUFA-related differences in lipoprotein-associated phospholipase A2 levels in patients with type 2 diabetes and atherosclerotic cardiovascular disease. | Adv Clin Exp Med | 2024 | 37747445 | PubTator, text mining | PubMed |
| Inflammation in acute myocardial infarction: the good, the bad and the ugly. | Eur Heart J | 2024 | 37587550 | PubTator, text mining | PubMed |
| Application of Shouwu Yizhi prescription in decubation of patients with ischemic stroke. | Biotechnol Genet Eng Rev | 2024 | 37067346 | PubTator, text mining | PubMed |
| Heat Inactivation of Host Cell-Derived Enzymes as a Control Strategy for Polysorbate Degradation. | J Pharm Sci | 2023 | 39492476 | PubTator, text mining | PubMed |
The 'analysis of gene expression and biomarkers for point-of-care decision support in Sepsis' study; temporal clinical parameter analysis and validation of early diagnostic biomarker signatures for severe inflammation andsepsis-SIRS discrimination. | Front Immunol | 2023 | 38332914 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7941/papers?page=14